Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Heilig

Showing results (221-230 of 313) with videos related to

Pageof 32
Sort By:
Development and Psychopathology|October 13, 2007
Association between the recombinant human serotonin transporter linked promoter region polymorphism and behavior in rhesus macaques during a separation paradigmSimona Spinelli, Melanie L Schwandt, Stephen G Lindell, et al.
The Lancet Regional Health. Europe|June 9, 2025
Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placebo-controlled multicentre trialBo Söderpalm, Helga Lidö, Johan Franck, et al.
Biological Psychiatry|February 1, 2011
Activation of nuclear PPARγ receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seekingSerena Stopponi, Lorenzo Somaini, Andrea Cippitelli, et al.
Addiction Biology|March 31, 2012
Medications development to treat alcohol dependence: a vision for the next decadeRaye Z Litten, Mark Egli, Markus Heilig, et al.
Lakartidningen|March 19, 2003
[Researchers and psychiatrists defending Gillberg's research on ADDH: Karfve's campaign is a form of personal persecution and scientific basis is missing]Rolf Adolfsson, Susanne Bejerot, Jörgen Engel, et al.
British Journal of Pharmacology|August 16, 2015
Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar ratsLydia O Ayanwuyi, Serena Stopponi, Massimo Ubaldi, et al.
Alcohol (Fayetteville, N.Y.)|December 15, 2010
The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxietyAndrea Cippitelli, Amir H Rezvani, J Elliott Robinson, et al.
Biological Psychiatry|February 23, 2010
Effects of early-life stress on serotonin(1A) receptors in juvenile Rhesus monkeys measured by positron emission tomographySimona Spinelli, Svetlana Chefer, Richard E Carson, et al.
Neuropharmacology|February 21, 2012
Reduced alcohol intake and reward associated with impaired endocannabinoid signaling in mice with a deletion of the glutamate transporter GLASTRose-Marie Karlsson, Louise Adermark, Anna Molander, et al.
Addiction Biology|April 21, 2012
The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxietyJesse R Schank, Andrea L Goldstein, Kelly E Rowe, et al.
Pageof 32

Showing results (221-230 of 313) with videos related to

Sort By:
Pageof 32
Development and Psychopathology|October 13, 2007
Association between the recombinant human serotonin transporter linked promoter region polymorphism and behavior in rhesus macaques during a separation paradigmSimona Spinelli, Melanie L Schwandt, Stephen G Lindell, et al.
The Lancet Regional Health. Europe|June 9, 2025
Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placebo-controlled multicentre trialBo Söderpalm, Helga Lidö, Johan Franck, et al.
Biological Psychiatry|February 1, 2011
Activation of nuclear PPARγ receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seekingSerena Stopponi, Lorenzo Somaini, Andrea Cippitelli, et al.
Addiction Biology|March 31, 2012
Medications development to treat alcohol dependence: a vision for the next decadeRaye Z Litten, Mark Egli, Markus Heilig, et al.
Lakartidningen|March 19, 2003
[Researchers and psychiatrists defending Gillberg's research on ADDH: Karfve's campaign is a form of personal persecution and scientific basis is missing]Rolf Adolfsson, Susanne Bejerot, Jörgen Engel, et al.
British Journal of Pharmacology|August 16, 2015
Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar ratsLydia O Ayanwuyi, Serena Stopponi, Massimo Ubaldi, et al.
Alcohol (Fayetteville, N.Y.)|December 15, 2010
The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxietyAndrea Cippitelli, Amir H Rezvani, J Elliott Robinson, et al.
Biological Psychiatry|February 23, 2010
Effects of early-life stress on serotonin(1A) receptors in juvenile Rhesus monkeys measured by positron emission tomographySimona Spinelli, Svetlana Chefer, Richard E Carson, et al.
Neuropharmacology|February 21, 2012
Reduced alcohol intake and reward associated with impaired endocannabinoid signaling in mice with a deletion of the glutamate transporter GLASTRose-Marie Karlsson, Louise Adermark, Anna Molander, et al.
Addiction Biology|April 21, 2012
The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxietyJesse R Schank, Andrea L Goldstein, Kelly E Rowe, et al.
Pageof 32